ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 1,430 Shares

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander sold 1,430 shares of the firm’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total value of $225,940.00. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Christian B. Voigtlander also recently made the following trade(s):

• On Monday, November 25th, Christian B. Voigtlander sold 1,962 shares of ICU Medical stock. The shares were sold at an average price of $169.08, for a total value of $331,734.96.

ICU Medical Stock Performance

ICUI traded up $2.00 on Wednesday, hitting $159.75. 245,094 shares of the company traded hands, compared to its average volume of 274,609. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The company has a 50 day moving average of $175.61 and a 200-day moving average of $146.51. ICU Medical, Inc. has a 12-month low of $83.26 and a 12-month high of $196.26. The stock has a market capitalization of $3.91 billion, a PE ratio of -34.62 and a beta of 0.66.

Analyst Ratings Changes

Several analysts have recently issued reports on ICUI shares. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Jefferies Financial Group began coverage on ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target on the stock. KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Raymond James upped their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, ICU Medical currently has a consensus rating of “Moderate Buy” and a consensus price target of $173.00.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the company. Innealta Capital LLC acquired a new position in ICU Medical in the second quarter valued at approximately $32,000. Hexagon Capital Partners LLC increased its stake in shares of ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 122 shares during the last quarter. Allworth Financial LP boosted its holdings in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in ICU Medical by 46.4% in the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 173 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 302 shares during the period. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.